Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 1.14B | £ 1.15B | £ 784.10M | £ 904.80M | £ 702.10M |
Total Assets | £ 4.64B | £ 4.60B | £ 4.35B | £ 4.63B | £ 6.73B |
Total Debt | £ 2.20B | £ 2.15B | £ 2.18B | £ 2.31B | £ 2.39B |
Net Debt | £ 1.06B | £ 998.90M | £ 1.39B | £ 1.41B | £ 1.69B |
Total Liabilities | £ 3.98B | £ 3.90B | £ 3.96B | £ 4.39B | £ 4.33B |
Stockholders Equity | £ 641.30M | £ 682.00M | £ 370.60M | £ 227.40M | £ 2.38B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |